ANI Pharmaceuticals ANIP Return on invested capital

Return on invested capital at other companies

Amneal Pharmaceuticals, Inc.AMRX

20.3%+10.3pp

ViatrisVTRS

-0.3%-0.2pp

AnaptysBio, Inc.ANAB

-255.3%-510pp

Eton Pharmaceuticals, Inc.ETON

-45.1%-22.2pp

Aurinia PharmaceuticalsAUPH

33.7%+20.8pp

Zevra Therapeutics, Inc.ZVRA

71.7%+48.7pp

FAQ

What is ANI Pharmaceuticals's return on invested capital?

ANI Pharmaceuticals (ANIP) reported return on invested capital of 21.3% in Q2 2026.

How has ANI Pharmaceuticals's return on invested capital changed year-over-year?

ANI Pharmaceuticals's return on invested capital increased by 52575.4% year-over-year, from -0% to 21.3%.

What is the long-term trend for ANI Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's return on invested capital has grown at a 28.3% compound annual growth rate (CAGR), from -4.5% to 15.7%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.